GB0025677D0 - New protein - Google Patents
New proteinInfo
- Publication number
- GB0025677D0 GB0025677D0 GBGB0025677.6A GB0025677A GB0025677D0 GB 0025677 D0 GB0025677 D0 GB 0025677D0 GB 0025677 A GB0025677 A GB 0025677A GB 0025677 D0 GB0025677 D0 GB 0025677D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- new protein
- protein
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0025677A GB2372503A (en) | 2000-10-19 | 2000-10-19 | Voltage-gated potassium channel polypeptides |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0025677A GB2372503A (en) | 2000-10-19 | 2000-10-19 | Voltage-gated potassium channel polypeptides |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0025677D0 true GB0025677D0 (en) | 2000-12-06 |
GB2372503A GB2372503A (en) | 2002-08-28 |
Family
ID=9901639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0025677A Withdrawn GB2372503A (en) | 2000-10-19 | 2000-10-19 | Voltage-gated potassium channel polypeptides |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2372503A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030236389A1 (en) * | 2000-12-15 | 2003-12-25 | Shimkets Richard A. | Proteins, polynucleotides encoding them and methods of using the same |
KR101390239B1 (en) * | 2006-04-27 | 2014-04-30 | 사노피-아벤티스 도이칠란트 게엠베하 | Inhibitors of the TASK-1 and TASK-3 ion channel |
JP5206882B2 (en) * | 2009-09-29 | 2013-06-12 | 味の素株式会社 | Screening method for salty taste modulators |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1313854A2 (en) * | 2000-07-07 | 2003-05-28 | Incyte Genomics, Inc. | Transporters and ion channels |
-
2000
- 2000-10-19 GB GB0025677A patent/GB2372503A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2372503A (en) | 2002-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0001704D0 (en) | Protein | |
GB0003079D0 (en) | Novel protein | |
GB0011185D0 (en) | Protein | |
GB0027905D0 (en) | New protein | |
GB0024446D0 (en) | Protein | |
GB0025677D0 (en) | New protein | |
GB0009181D0 (en) | Protein | |
IL150774A0 (en) | Apoptin-associating protein | |
EP1323734A4 (en) | Irap-binding protein | |
EP1179592A4 (en) | Proteins nectin-3 | |
GB0119929D0 (en) | Protein | |
GB0008549D0 (en) | Protein | |
GB0001700D0 (en) | Novel protein | |
GB0124035D0 (en) | New protein | |
GB0010596D0 (en) | New protein | |
GB0128025D0 (en) | New protein | |
GB0013639D0 (en) | New protein | |
GB0014158D0 (en) | New protein | |
GB0025059D0 (en) | New protein | |
GB0027908D0 (en) | New protein | |
GB0014825D0 (en) | Protein | |
GB0011056D0 (en) | Protein | |
GB0030294D0 (en) | Protein | |
GB0015307D0 (en) | Protein | |
GB0008774D0 (en) | Protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |